Perriman Damien Alan (CIK 2096714) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-25). Recent activity: Buy EXOZ (19,612 shares), Buy EXOZ (8,887 shares), Buy EXOZ (62,759 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | EXOZYMES INC. (EXOZ) | Chief Commercial Officer | Buy | 19,612 | $0 |
| 2026-04-08 | EXOZYMES INC. (EXOZ) | Chief Commercial Officer | Buy | 8,887 | $75,006 |
| 2026-04-08 | EXOZYMES INC. (EXOZ) | Chief Commercial Officer | Buy | 62,759 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25